MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth
Open Access
- 27 June 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 67287-67299
Abstract
MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growthKeywords
This publication has 40 references indexed in Scilit:
- Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migrationOncotarget, 2016
- Dual Roles of RNF2 in Melanoma ProgressionCancer Discovery, 2015
- Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19ARF/p53 axis in hematopoiesis, early T-cell development and tissue differentiationCell Death & Differentiation, 2015
- PAX3 and ETS1 synergistically activate MET expression in melanoma cellsOncogene, 2014
- Melanoma: Clinical Features and Genomic InsightsCold Spring Harbor Perspectives in Medicine, 2014
- High expression of DNA repair pathways is associated with metastasis in melanoma patientsOncogene, 2007
- A Histone H2A Deubiquitinase Complex Coordinating Histone Acetylation and H1 Dissociation in Transcriptional RegulationMolecular Cell, 2007
- Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variantsHuman Mutation, 2007
- PAX3 is expressed in human melanomas and contributes to tumor cell survival.2001
- Pax3 modulates expression of the c-Met receptor during limb muscle development.Proceedings of the National Academy of Sciences, 1996